06826.HK
Shanghai Haohai Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 16.73
−0.36%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.5x
Market Cap
HKD 3.77B
MomentumView details →
1D Return
−0.36%
YTD Return
−31.43%
RSI (14)
54.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.5x
Market Cap
HKD 3.77B
RSI (14)
54.0
MomentumView details →
1D Return
−0.36%
YTD Return
−31.43%
Similar companies
Latest newsMore news →
Shanghai Haohai Biological Technology Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 113 million yuan, down 46.64% year-on-year.14d agoShanghai Haohai Biological Technology Co., Ltd. announced a cash dividend of 2.5 yuan per 10 shares (tax inclusive), totaling 56.1875 million yuan (tax inclusive).14d ago